IMUNON is incorporated in the State of Delaware
The Company's fiscal year end is December 31.
IMUNON's corporate headquarters is located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648
We have 25 full-time employees and occasionally utilize the services of part-time consultants.
The members of our Board of Directors can be found in the ABOUT US section of our web site, under Board of Directors.
Corinne Le Goff is IMUNON's President and Chief Executive Officer. Other members of our management team can be found in the ABOUT US section of our web site, under Leadership Team.
The Company's shares are traded on the NASDAQ Stock Exchange under the symbol "IMNN."
The Company's transfer agency is American Stock Transfer & Trust Company, 59 Maiden Lane, New York, New York 10038, phone (212) 936-5100.
WithumSmith+Brown, PC, Princeton, NJ.
Registered stockholders should contact the Company's transfer agent and registrar, American Stock Transfer & Trust Company, 59 Maiden Lane, New York, New York 10038, phone (212) 936-5100.
The Company's fiscal year end is December 31; subsequent quarters are March 31, June 30, and September 30. IMUNON releases its earnings results as soon as practical following each of these dates within the bounds of required reporting dates as defined by the SEC. The time and date of our conference call can be found on the Events section of the Company's web site.
IMUNON does not pay a cash dividend.
Please refer to the Governance section of our web site for the Company's Corporate Governance Policy.
Contact information is available on our web site under Contact.